Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mahrukh Huseni
Anti-Tumor Efficacy and Biomarker Evaluation of Agonistic Anti-Ox40 Antibodies in Preclinical Models
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Development of a Robust Flow Cytometry-Based Pharmacodynamic Assay to Detect Phospho-Protein Signals for Phosphatidylinositol 3-Kinase Inhibitors in Multiple Myeloma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Anti-Vegfr2 Therapy Delays Growth of Preclinical Pediatric Tumor Models and Enhances Anti-Tumor Activity of Chemotherapy
Oncotarget
Oncology
Ligand-Blocking and Membrane-Proximal Domain Targeting Anti-Ox40 Antibodies Mediate Potent T Cell-Stimulatory and Anti-Tumor Activity
Cell Reports
Biochemistry
Genetics
Molecular Biology
S100A4 Blockage Alleviates Agonistic Anti-Cd137 Antibody-Induced Liver Pathology Without Disruption of Anti-Tumor Immunity
OncoImmunology
Oncology
Allergy
Immunology
Niraparib Activates Interferon Signaling and Potentiates Anti-Pd-1 Antibody Efficacy in Tumor Models
Scientific Reports
Multidisciplinary
Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer
Cancers
Cancer Research
Oncology
Preparative Immunotherapy With Anti-Ox40 and Anti-Ctla4 Improves the Response to Chemotherapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Anti-Idiotypic Antibodies and “Tumor-Only” Antigens: An Update
The Open Immunology Journal
PD-L1 Checkpoint Blockade Delivered by Retroviral Replicating Vector Confers Anti-Tumor Efficacy in Murine Tumor Models
Oncotarget
Oncology
LY3009120, a panRAF Inhibitor, Has Significant Anti-Tumor Activity in BRAF and KRAS Mutant Preclinical Models of Colorectal Cancer
Oncotarget
Oncology
